The honest answer is that we don't fully know yet — and that should matter to any Toronto man weighing whether to start, continue, or stop semaglutide. Ozempic has only been on the market since 2017 for type 2 diabetes and even less time for off-label weight loss use. The longest published trials run about three to four years. Anyone telling you the long-term safety profile is settled is filling in blanks the research hasn't filled in yet. What we do know — and what 2026 data has clarified — is that the short-term side effects are common, the rare serious risks are real, and the drug is designed to be taken for life. That last point is the one most men miss when they ask whether it's safe.

We've been coaching men through weight loss in Toronto since 1985, and we now see two kinds of GLP-1 patients walking into our North York clinic almost every week. The first is the man considering starting. He wants to know if it's a safe bet. The second is the man who's been on it for eighteen months or two years and is starting to wonder what the next five or ten years look like. This guide is for both of them. It covers what the 2026 evidence actually shows about long-term semaglutide safety in men, the side effects worth taking seriously, and why "is it safe" is often the wrong question to be asking in the first place.

The Short Answer: What 2026 Evidence Actually Shows

The data we have today, drawn from the longest randomized trials and the largest real-world patient registries, paints a mixed picture. Most men tolerate semaglutide reasonably well in the short term. Common side effects — nausea, diarrhea, constipation, fatigue, reflux — are usually manageable and tend to ease as the body adjusts. The pounds come off. Blood sugar improves in men with type 2 diabetes. Cardiovascular events drop modestly in higher-risk patients.

The cautions sit on a different timescale. A 2024 study published in JAMA Ophthalmology flagged a higher risk of a rare optic-nerve condition called NAION in semaglutide users. The FDA has been actively investigating. Real-world registries continue to report pancreatitis at low but measurable rates — roughly 0.24% in one large semaglutide review. Concerns about thyroid C-cell tumours, originally raised in rodent studies, remain a "monitor carefully" item rather than a confirmed human risk after several years of human data. And the body-composition issue — the fact that about 20% to 25% of weight lost on Ozempic in men is lean muscle, not fat — is now well documented.

None of this means the drug is unsafe for every man. It means the long-term picture is still being assembled in real time, and the men taking it are the ones generating the data.

What "Long Term" Actually Means With a Drug Designed for Life

Most prescriptions have a defined start and stop. Antibiotics for a week. Blood pressure medication that may or may not be lifelong depending on lifestyle. Ozempic and Wegovy weren't designed that way. They work only while you're injecting them — when you stop, appetite and weight rebound for the majority of patients, as we covered in detail in What Happens When You Stop Taking Ozempic.

So when a man asks if Ozempic is safe long term, the real question hiding inside it is: am I prepared to take a weekly injection for the rest of my life, with whatever the next decade of evidence turns up about it? Because that's the practical commitment. A man in his forties starting semaglutide today is signing up — financially, biologically, and behaviourally — for a 30- to 40-year prescription if he wants the weight loss to stick.

That's not a reason to refuse the drug. It is a reason to be honest with yourself about what "long term" means in this context. Most of the long-term safety data we have stops at three or four years. Year ten, year twenty, year thirty — those are blank pages right now.

The Side Effects Most Men Notice First

The short-term side effect picture is well understood, and it shows up in the first few weeks for most men. Gastrointestinal symptoms lead the list: nausea, vomiting, diarrhea, constipation, reflux, excessive burping, stomach pain. Many men also report fatigue, mild headaches, and a noticeable drop in appetite that goes beyond feeling full — closer to a loss of interest in food altogether.

For most patients these symptoms ease over the first two or three months as the dose stabilizes. For a meaningful minority — somewhere between 5% and 10% in published trials — the GI side effects are bad enough to cause discontinuation. Men who already have gallbladder issues, a history of pancreatitis, or significant reflux tend to have a rougher time. Toronto men who travel for work or eat irregular meals also report struggling with the timing of meals around the injection schedule.

The Serious Risks That Made the News in 2024 and 2025

Three serious risks deserve direct attention because they've been the subject of regulatory scrutiny in the past two years.

The first is acute pancreatitis. In real-world data from one large semaglutide review, about 0.24% of patients — roughly one in 400 — developed acute pancreatitis during treatment. That's a small percentage but a real one, and it's the reason GLP-1 prescribers screen for personal and family history of pancreatic disease before starting therapy. Symptoms can include severe upper abdominal pain that radiates to the back, nausea, and vomiting, and they warrant an immediate medical assessment.

The second is the optic nerve. A 2024 JAMA Ophthalmology study reported a significantly higher rate of non-arteritic anterior ischemic optic neuropathy — NAION — among patients taking semaglutide-containing medications. NAION can cause sudden, painless vision loss in one eye and is irreversible once it occurs. The condition is rare in the general population, and the absolute risk for any individual semaglutide patient remains low, but the relative increase prompted the FDA to open an investigation that is still active in 2026.

The third is the thyroid question. Ozempic carries a boxed warning in the United States about thyroid C-cell tumours because rodent studies showed elevated rates of these tumours during long-term semaglutide exposure. Whether the same risk translates to humans remains unproven after several years of post-market data. Recent systematic reviews suggest the absolute incidence of thyroid cancer in semaglutide patients remains low. The FDA, Health Canada, and prescribers continue to advise against the drug in men with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

These are the risks that warrant a direct conversation with a prescribing physician — not the kind of decisions to make off a TikTok ad or a friend's recommendation.

The Muscle, Bone, and Metabolism Question

The risks above involve relatively rare outcomes. The body-composition risk is nearly universal, and we think it gets too little attention in the conversation about long-term safety.

Roughly 20% to 25% of the weight a man loses on semaglutide is lean muscle, with one landmark trial measuring a 13.9% drop in lean body mass over 68 weeks. For Toronto men over 40, who are already losing about 1% of muscle mass per year through normal aging, that loss compounds into something hard to undo. We covered the muscle dynamics in detail in Does Ozempic Cause Muscle Loss in Men?. The short version: less muscle means lower resting metabolism, worse insulin sensitivity, weaker grip and strength in daily life, and a higher long-term risk of falls and fractures.

Bone density losses have also been measured in some studies, though the long-term implications are still being worked out. For a man in his fifties or sixties, a sustained calorie deficit without resistance training can chip away at bone mineral density at the same time it's chipping away at muscle. That trade-off — pounds down, lean mass and bone down — is the part of the safety story that doesn't usually get summarized at the prescriber's office.

Reserve your free introductory session at Harvey Brooker Weight Loss for Men and our coaches will walk you through how our 20/20 Healthy Eating Plan protects lean mass while taking fat off — the way over 10,000 Toronto-area men have done it since 1985.

Why "Long-Term Safe" Is the Wrong Question for Toronto Men

After 40 years of coaching men through weight loss across the GTA, we've come to believe the safety conversation around Ozempic is framed too narrowly. The right question isn't "is this drug safe?" It's "is this approach going to give me the body and health I want over the next twenty years?"

A man can take semaglutide for two years, lose 50 pounds, develop none of the serious side effects, and still end up worse off than when he started — if he loses 15 pounds of muscle in the process, regains the fat after stopping, and never builds the eating and movement habits that hold the weight off. That's a "safe" course of treatment by any clinical definition. It's also a poor long-term outcome.

The alternative isn't to refuse all medical help. It's to recognize that for the vast majority of men dealing with weight, the durable answer is the one that doesn't depend on a weekly injection forever. It's the eating plan, the structure, the accountability, and the social support that keep the work intact when the prescription ends — or when the next safety signal lands and changes the calculation.

What 40 Years of Coaching Men in Toronto Has Shown Us

Our program has never used drugs, shakes, or surgery. Since 1985 we've coached over 10,000 men across Toronto, the GTA, and Ontario to lose weight by changing what they eat, how often they eat, and the structure they build around it. The fact that we don't use medication isn't a marketing position — it's the entire point.

In practice that looks like this. We teach you the 20/20 Healthy Eating Plan, which centres protein at every meal and uses real food in satisfying portions. There's no calorie counting, no powder, no meal replacement to buy. You get weekly group coaching with men who are in the same fight you're in, led by coaches who specialize in men's weight loss specifically. Many Ontario insurance providers cover the program, so most of our members pay far less out of pocket than they'd spend on a year of semaglutide injections — and the result doesn't expire when a prescription does.

The men who come to us before starting Ozempic, during their time on it, or after stopping it all end up in the same place: lean, strong, and confident that what they've built doesn't disappear the moment a weekly injection stops working.

Frequently Asked Questions

Is Ozempic safe for long-term use in men?

The short-term safety profile is reasonably well established, with manageable side effects for most patients. The long-term picture — meaning ten, twenty, or thirty years of continuous use — is still being studied because the drug hasn't been on the market that long. Rare but serious risks like pancreatitis, NAION, and possible thyroid effects continue to be monitored. Most men also experience meaningful muscle loss during treatment, which has its own long-term metabolic implications.

What are the worst side effects of Ozempic for men?

The most common are gastrointestinal: nausea, vomiting, diarrhea, constipation, reflux, and fatigue. The rare but more serious risks include acute pancreatitis, gallbladder problems, vision loss from NAION, kidney issues related to dehydration, and possible thyroid concerns. Loss of lean muscle is nearly universal and often goes unnoticed until strength starts dropping in everyday tasks.

Can I take Ozempic safely for the rest of my life?

That's the practical question, because the drug only works while you're on it. We don't yet have multi-decade data on continuous semaglutide use in healthy adults. The cost over a lifetime is significant — likely well over $100,000 in injections alone — and the safety picture beyond five years is still being filled in. For most men, building a sustainable lifestyle that doesn't require a permanent prescription is the more reliable long-term answer.

Is Ozempic safer than weight loss surgery?

Both carry risks, and both can produce significant weight loss. Surgery is a one-time procedure with a defined recovery and a permanent anatomical change. Ozempic is an indefinite prescription with risks that accumulate over time. Neither addresses the underlying eating and behavioural patterns that drove the weight gain. A structured lifestyle program is the lowest-risk option of the three for most men — and often the most effective long term.

What's a safer long-term option than Ozempic in Toronto?

A structured lifestyle program designed for men. At Harvey Brooker Weight Loss for Men, we've coached 10,000+ men across the GTA to lose weight and keep it off since 1985 with no injections, no pills, and no shakes. Many Ontario insurance plans help cover the cost. The risk profile is essentially zero, the cost is a fraction of GLP-1 therapy, and the result is durable rather than rented.

Should I read your other Ozempic articles before deciding?

Yes. If you're weighing whether to start, the post on Real Talk: Ozempic is Harmful to Your Body and Wallet covers the financial and side-effect picture in more depth. If you're already on it and considering stopping, What Happens When You Stop Taking Ozempic walks through the rebound process. And if you're worried about muscle, the muscle-loss companion piece is the most current breakdown.

Real advice. Real results. If you could do it alone, you would have done it already.

Reserve your free introductory session today.

This article is general information for Toronto men weighing weight-loss options and does not replace medical advice. Talk to your physician before starting, continuing, or stopping any prescription medication.

By the Harvey Brooker Team